ISSUE 2

Including selected proceedings of the 6th International ESCOP Symposium

Herbal Medicinal Products: Scientific Strategies in Europe

Beethovenhalle, Bonn
10-11th May 2001

This second issue of The European Phytojournal is under construction. Articles are posted as they are ready and have not yet been paginated as one volume for citation purposes. All are downloadable pdf files as in Issue 1. There will also be other downloadable materials, not formally in the second issue, that will require different programs.

 

Regulation of herbal medicinal products

Developments in the regulation of medicinal products.
Dr Paul Weissenberg, Director, Single Market, regulatory environment, DG Enterprise, European Commission, Brussels

The "well-established use" Directive - its application to herbal medicinal products in Europe.
Prof. Dr Konstantin Keller, EMEA Herbal Medicinal Product Working Party

The "traditional use" Directive - where are we now?
Mr Richard Woodfield, MCA, London

The new regulatory landscape in Europe for herbal medicinal products - what does this mean for the industry?
Dr Bernd Eberwein, BAH, Bonn

Complying with the law - applying for marketing authorisations in a changing landscape.
Mr Jeff Kaufman, Yarra SA, Paris

Interactions

Xenobiotics - the impact on the body of secondary plant metabolites.
Dr C. Ioannides, Molecular Toxicology Group, University of Surrey, Guildford

Hypericum interactions - an update.
Dr Bernhard Uehleke, Berlin

Synergy: interactions within herbal medicines.
Dr. E.M. Williamson, School of Pharmacy, University of London

Adverse reports - some first principles.
Dr. Desmond Corrigan, Trinity College, Dublin

Levels of Evidence

Assessing claims for efficacy by applying EBM and Meta-analyses.
Professor Überla, Munich

What is "traditional use" evidence?
Dr Karin Kraft, Commission E, Bonn

Guidelines for the assessment of efficacy of phytomedicines in the Netherlands.
Dr Ary van der Kuy, Loon op Zand, Netherlands 

Evidence for the clinician - a pragmatic framework for phytotherapy.
Mr Simon Y. Mills, University of Exeter

Black Cohosh (Cimicifuga racemosa).
Dr Normann Boblitz, Hanover

Hawthorn (Crataegus spp).
Dr Günter Meng, Karlsruhe

Welcome address during the Reception of the Symposium
Dr. Dieter Thomae

Posters

Fixed combination herbal medicinal products from non-European traditions provide solutions for multi-factorial diseases - the example of Tibetan medicine.
Dr Elisabeth McHugh

A prospective, open, uncontrolled study of a standardised extract of St. John's wort (Hypericum perforatum L; LI-160) as an aid in smoking cessation: preliminary results.
Ms Joanne Barnes

Experiences with herbal products: a survey of community pharmacists in England.
Ms Joanne Barnes

A new COX-2 inhibitory agent isolated from Achillea millefolium L and Matricaria recutita L.
Dr Peter Imming

Anti-inflammatory activity of three newly developed Harpagophytum procumbens extracts.
Dr Michel Weber

Effects of four different Ginkgo biloba extract-doses on retinal blood flow of healthy volunteers.
Dr Michel Weber

Influence of an Arnica-Gel on the transcription factor NF-kB.
Dr Michel Weber

Salmonella typhimurium reverse mutation assay with the Serenoa repens extract Prostasan.
Dr Michel Weber

Effect of Kava and Valerian on physiological and psychological responses to mental stress assessed under laboratory conditions.
Dr Mark Cropley

Efficacy and tolerability of the herbal preparation STW-5 in the therapy of functional dyspepsia: results of a double-blind placebo-controlled randomised multicenter trial.
Dr Irena Sassin

A randomised double-blind multicenter comparison of a herbal preparation STW-5 with cisapride in the treatment of dysmobility type of functional dyspepsia.
Dr Irena Sassin

Treatment results of 11,296 outpatients with St. John's wort extract (LAIF 600) in a single dose regimen.
Dr Karin Zeller

Significant improvement of quality of life during clinical use of a vitamin preparation - a postmarketing surveillance with 3179 patients.
Dr Karin Zeller

Food and inflammation: one third of Swedish food plants have anti-inflammatory records.
Dr Jan G Bruhn

Evaluation of a phytopharmaceutical preparation containing Cynara extract.
Dr Nebal El-Tanbouly

Clinical evaluation of Japanese phytotherapy (Gosha-Jinki-Gan) in diabetic neuropathy: a prospective open pilot study.
Dr Heidrun Reissenweber

A study of an herbal anxiolytic in generalised anxiety disorder.
Dr Kathryn M. Connor

Effects of longterm treatment with stevioside on the Type 2 diabetic Goto-Kakisaki (GK) rats - potential of a new antidiabetic drug.
Dr Per Bendix Jeppesen

DCXF on experimental migraine model: an inhibition effect on c-fos gene expression.
Dr Ying Wang

The mechanisms of DCXF on migraine: a block effect on Ca²⁺ channel.
Professor Dong Zhou

NMR analysis of HDP's: the case of St John's wort extracts.
Dr Anna Rita Bilia

Dissolution behaviours of some commercial herbal drugs and their preparations content.
Dr Anna Rita Bilia

On the presence of heavy metals in ayurvedic preparations: analytical problems and toxicological aspects.
Dr Maria Ciprotti

Appendix

1) Additional web based material

The following material is provided as Microsoft Word and Microsoft Powerpoint files.  Users who do not have the full versions of these Microsoft products can download viewer software from Microsoft's website.

Return to European Phytojournal contents